Clinical trial
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the…
NCT00050752 · National Cancer Institute (NCI), NIH · Recruiting
Key facts
| NCT number | NCT00050752 |
|---|---|
| Title | Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer |
| Official title | Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene, and Characterization of the Predisposition to Renal Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Renal Tumor Histology, Cutaneous Leiomyoma, Kidney Cancer |
| Enrollment | 1,130 |
| Start date | Feb 24, 2003 |
| First posted | Dec 18, 2002 |
| Last update posted | Jan 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: